Ratios Revealed: Decoding Vera Therapeutics Inc (VERA)’s Financial Health

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $42.06 for the day, up 1.57% from the previous closing price of $41.41. In other words, the price has increased by $1.57 from its previous closing price. On the day, 0.53 million shares were traded. VERA stock price reached its highest trading level at $42.29 during the session, while it also had its lowest trading level at $40.485.

Ratios:

Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.60 and its Current Ratio is at 13.60. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on November 21, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.

On January 25, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.Oppenheimer initiated its Outperform rating on January 25, 2024, with a $26 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 18 ’24 when Fordyce Marshall sold 17,500 shares for $43.07 per share. The transaction valued at 753,680 led to the insider holds 85,942 shares of the business.

MARSHALL FORDYCE bought 17,500 shares of VERA for $768,425 on Dec 18 ’24. On Dec 11 ’24, another insider, Fordyce Marshall, who serves as the PRESIDENT AND CEO of the company, sold 17,500 shares for $46.94 each. As a result, the insider received 821,523 and left with 85,942 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2663369728 and an Enterprise Value of 2323808512.

Stock Price History:

Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $14.20. The 50-Day Moving Average of the stock is -7.06%, while the 200-Day Moving Average is calculated to be 3.26%.

Shares Statistics:

VERA traded an average of 753.27K shares per day over the past three months and 743900 shares per day over the past ten days. A total of 55.03M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 22.63% of the company’s shares, while institutions hold 77.55% stake in the company. Shares short for VERA as of 1734048000 were 6798203 with a Short Ratio of 9.02, compared to 1731628800 on 6546438. Therefore, it implies a Short% of Shares Outstanding of 6798203 and a Short% of Float of 14.32.

Most Popular